These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders. Malar DS; Thitilertdecha P; Ruckvongacheep KS; Brimson S; Tencomnao T; Brimson JM CNS Drugs; 2023 May; 37(5):399-440. PubMed ID: 37166702 [TBL] [Abstract][Full Text] [Related]
3. NMDARs mediate peripheral and central sensitization contributing to chronic orofacial pain. Liu YJ; Li YL; Fang ZH; Liao HL; Zhang YY; Lin J; Liu F; Shen JF Front Cell Neurosci; 2022; 16():999509. PubMed ID: 36238833 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia. Moore D; Chong MS; Shetty A; Zakrzewska JM Br J Anaesth; 2019 Aug; 123(2):e385-e396. PubMed ID: 31208761 [TBL] [Abstract][Full Text] [Related]
5. Expanding Role of NMDA Receptor Antagonists in the Management of Pain. Kreutzwiser D; Tawfic QA CNS Drugs; 2019 Apr; 33(4):347-374. PubMed ID: 30826987 [TBL] [Abstract][Full Text] [Related]
6. Trigeminal Neuralgia, Glossopharyngeal Neuralgia, and Myofascial Pain Dysfunction Syndrome: An Update. Khan M; Nishi SE; Hassan SN; Islam MA; Gan SH Pain Res Manag; 2017; 2017():7438326. PubMed ID: 28827979 [TBL] [Abstract][Full Text] [Related]
7. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations. Gewandter JS; Dworkin RH; Turk DC; McDermott MP; Baron R; Gastonguay MR; Gilron I; Katz NP; Mehta C; Raja SN; Senn S; Taylor C; Cowan P; Desjardins P; Dimitrova R; Dionne R; Farrar JT; Hewitt DJ; Iyengar S; Jay GW; Kalso E; Kerns RD; Leff R; Leong M; Petersen KL; Ravina BM; Rauschkolb C; Rice ASC; Rowbotham MC; Sampaio C; Sindrup SH; Stauffer JW; Steigerwald I; Stewart J; Tobias J; Treede RD; Wallace M; White RE Pain; 2014 Sep; 155(9):1683-1695. PubMed ID: 24865794 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the effect of dextromethorphan and ketamine on the acute nociceptive threshold and wind-up of the second pain response in healthy male volunteers. Hughes AM; Rhodes J; Fisher G; Sellers M; Growcott JW Br J Clin Pharmacol; 2002 Jun; 53(6):604-12. PubMed ID: 12047485 [TBL] [Abstract][Full Text] [Related]
9. Drug interactions with patient-controlled analgesia. Lotsch J; Skarke C; Tegeder I; Geisslinger G Clin Pharmacokinet; 2002; 41(1):31-57. PubMed ID: 11825096 [TBL] [Abstract][Full Text] [Related]
10. Oxycodone for neuropathic pain and fibromyalgia in adults. Gaskell H; Moore RA; Derry S; Stannard C Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205 [TBL] [Abstract][Full Text] [Related]
11. Other facial neuralgias. O'Neill F; Nurmikko T; Sommer C Cephalalgia; 2017 Jun; 37(7):658-669. PubMed ID: 28133989 [TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Gilron I; Booher SL; Rowan MS; Smoller MS; Max MB Neurology; 2000 Oct; 55(7):964-71. PubMed ID: 11061252 [TBL] [Abstract][Full Text] [Related]
13. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Nelson KA; Park KM; Robinovitz E; Tsigos C; Max MB Neurology; 1997 May; 48(5):1212-8. PubMed ID: 9153445 [TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Sang CN; Booher S; Gilron I; Parada S; Max MB Anesthesiology; 2002 May; 96(5):1053-61. PubMed ID: 11981142 [TBL] [Abstract][Full Text] [Related]
15. Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia. Klepstad P; Borchgrevink PC Acta Anaesthesiol Scand; 1997 Mar; 41(3):422-6. PubMed ID: 9113190 [TBL] [Abstract][Full Text] [Related]